Lupin Limited is a pharmaceutical company that mainly targets the cardiovascular, anti-infective, and diabetology markets. Catering to the branded and generic markets in the US, the company's Suprax brand, a pediatric antibiotic used to treat throat and kidney problems, is its top-selling product in the country. Other chief products include Antara (cholesterol reduction), Locoid lotion (for topical use), Alinia (digestive problems), and InspiraChambers (antistatic valved holding chamber for delivery in the lungs). Overall, Lupin is among the market leaders within the cardiovascular (antituberculosis) market and caters to Europe, India, South Africa, and the US, among other regions.
Financial data as of March 31, 2019 (12 month period) in USD
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Essential information for a successful call
EMPLOYEES (All Sites)
- ASSETS (MIL USD) 3,944
REVENUE (MIL USD)
- TICKER SYMBOL 500257
- Incorporated 1991
- FISCAL YEAR END MAR
- SALES GROWTH % 5.75%
- NET INCOME GROWTH 141.4%
Get in Touch with 20 Contacts and 13 Principals*
Vinita Deshbandhu GuptaChief Executive Officer
Nilesh Deshbandhu GuptaManaging Director
Manju Deshbandhu GuptaDirector and Chairperson
Kamal Kishore SharmaDirector and Vice Chairperson